Navigation Links
BioNanomatrix Founder and CSO Dr. Han Cao Awarded Chinese Rising Star Entrepreneur Award

PHILADELPHIA, Oct. 7 /PRNewswire/ -- BioNanomatrix, Inc., which is developing and commercializing breakthrough single-molecule genomic analysis technology, announced today that Founder and Chief Scientific Officer, Han Cao, Ph.D., was awarded the Chinese Rising Star Entrepreneur Award at the China International Economic and Technical Cooperation Forum in Beijing, China on September 27, 2010.  The award is in recognition of Dr. Cao's entrepreneurial spirit and success in the founding of BioNanomatrix and the development of the Company's novel genomic analysis technology.  

Commenting on the milestone, Edward L. Erickson BioNanomatrix's president and chief executive officer, said: "This is a very great honor for Han and for the company he founded, BioNanomatrix.  We believe that the largest country markets for our products are the USA and China, with China rapidly becoming a world leader in genomics and life science research generally.  We look forward to mutually beneficial collaboration with Chinese research institutions and scientists as we commercialize our revolutionary technology."

About BioNanomatrix

BioNanomatrix, Inc., a privately held genomics company, is developing and commercializing game-changing, proprietary technologies for analysis of large biological molecules, such as nucleic acids that are extremely important in life science research, clinical diagnostic applications, and development of new therapeutics.  This technology is designed to reduce dramatically the time and complexity to analyze the genome.  BioNanomatrix's products will provide users with the means to perform single-molecule analyses on minute biological samples that are essentially impossible, impractical or too expensive with current technology.  For more information, visit:

Note: NANOANALYZER is a registered trademark of BioNanomatrix, Inc. The names of other companies, other entities, products and/or services mentioned herein may be the trademarks of their respective owners. Media Contact:  Tiberend Strategic Advisors, Inc. (212) 827-0020 Farrell   orAndrew Mielach  

SOURCE BioNanomatrix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioNanomatrix Announces Appointment of Dr. Pui-Yan Kwok to Its Scientific Advisory Board
2. BioNanomatrix Appoints Michael Kochersperger as Vice President of Engineering
3. BioNanomatrixs Revolutionary Whole Genome Analysis Platform Named to MIT Technology Reviews Annual 10 Emerging Technologies List
4. BioNanomatrix Appoints Genomic Research Experts Charles Lee and David L. Barker as Advisers
5. BioNanomatrix Awarded Supplemental Funding to Accelerate Commercialization of Innovative Single-Molecule Analyzer
6. Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecker to Board
8. Boston Scientific Provides Update on Involuntary Selling of Its Stock by Co-Founders
9. Fina Technologies Names Spotfire Founder Christopher Ahlberg to Board of Directors
10. Amylin Co-Founder Announces Plans to Vote for Eastbourne Slate
11. Scripps Research Institute Highlights Groundbreaking Work of aTyr Pharma Scientific Co-Founder
Post Your Comments:
(Date:6/24/2016)... on a range of subjects including policies, debt and investment ... Speaking at a lecture to the Canadian Economics ... the country,s inflation target, which is set by both the ... "In certain areas there needs to be frequent ... not sit down and address strategy together?" He ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in ... peritoneal or pleural mesothelioma. Their findings are the subject of a new article on ... biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients that ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
Breaking Biology Technology:
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/26/2016)... , April 27, 2016 ... "Global Multi-modal Biometrics Market 2016-2020"  report to their ... , The analysts forecast the global ... of 15.49% during the period 2016-2020.  ... of sectors such as the healthcare, BFSI, transportation, ...
Breaking Biology News(10 mins):